s6y
Company name or ticker
Search
Apimeds Pharmaceuticals US, Inc.
4
Kogan Elona: Statement of changes in beneficial ownership of securities
Filed
Friday, October 24, 2025
Period
Oct 15, 2025
Accession number
0001679971-25-000007
Documents
PRIMARY DOCUMENT
4
POWER OF ATTORNEY
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header